Beloved for his compassion on Caught in Providence, Judge Frank Caprio inspired millions with his humane approach to justice
A new study reveals that respiratory infections like common flu and coronavirus can awaken dormant breast cancer cells in the lungs, raising concerns for survivors
AI helped health professionals to better detect pre-cancerous growths in the colon, but when the assistance was removed, their ability to find tumors dropped by about 20 per cent
A new California study reveals that cannabis use disorder is linked to a threefold rise in oral cancer risk, challenging the belief that marijuana is a 'safe' drug
A global study finds that walking 7,000 steps daily can significantly reduce the risk of death by heart disease, diabetes, dementia and more, offering a practical alternative to the 10,000-step target
AI tool predicts liver cancer relapse with 82% accuracy, tackling a disease causing third-highest cancer-related deaths globally
Muscle loss in cancer patients is a major health problem, but the exact causes of how precisely tumors affect muscles remain an active area of research
Under the agreement, AbbVie will get exclusive rights to develop, manufacture and commercialize ISB 2001 in North America, Europe, Japan and Greater China
lobal estimate links 76 per cent of projected lifetime cases to H. pylori and urges mass screening, with India expected to see over 1.6 million cases
A mutation in the immune protein FasL may make humans more vulnerable to solid tumours, but scientists say it could be fixed through combination immunotherapy
A new study finds that psilocybin, the hallucinogenic compound in magic mushrooms, can offer long-term relief from depression and anxiety in cancer patients
Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement. The approved ANDA is therapeutically equivalent to the reference-listed drug product (RLD), Doxil Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL), of Baxter Healthcare Corporation, it added. Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of ovarian Cancer, AIDS-Related Kaposi's sarcoma, and multiple myeloma, the company said. Citing IQVIA data, Alembic said Doxorubicin Hydrochloride Liposome injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2mg/mL) single-dose ...
A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major contributing factor in the rise of cancers in young Indians, particularly among those in their twenties and thirties. With increasing cases of cervical, oral, and oropharyngeal cancers linked to HPV infection, experts believe India is on the brink of a preventable cancer crisis if urgent measures are not implemented. Dr Ashish Gupta, Chief of Medical Oncology at Amerix Cancer Hospital, New Delhi, said, "HPV-related cancers are striking far earlier than we used to see. Patients in their twenties are coming in with cervical, oral, and throat cancers -- many of which could have been avoided entirely with timely vaccination and proper awareness." "What's most heartbreaking is that HPV is preventable, yet many families and individuals are not even aware of the risk," Dr Gupta said. Unlike other cancers that develop over decades, HPV-related cancers in young people often .
Experts believe that the drug still holds potential for future market entry, and the current development should be viewed as a temporary setback
Kidney cancer often starts with habits built in your 20s and 30s-doctors explain how to lower your risk through simple lifestyle changes
A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially transforming early treatment and survival rates
World Blood Donor Day 2025: World Donor Day is observed every year on June 14 to recall the importance of blood donation for the healthcare system across the world
CureVac about a year ago opted to focus on oncology when it agreed to sell its remaining influenza and COVID-19 vaccine development to its alliance partner, Britain's GSK
Tata Memorial Centre has tied up with Wipro GE HealthCare Technologies Inc to establish a Cancer Research & Innovation Centre. The collaboration aims to strengthen clinical research and academic engagement activities with the establishment of a 'Joint Working Group' to determine key project areas and a collaboration roadmap for the next five years, Tata Memorial Centre (TMC) said in a statement. "The government is adopting a strategic, policy-driven approach to fight cancer with the establishment of daycare centres, expansion of cancer care ecosystem, promoting cancer screenings and awareness programmes. However, early detection, equitable access and preventive care remain a challenge," Tata Memorial Hospital Director CS Pramesh stated. With Wipro GE HealthCare, TMC aims to enhance clinical research and promote academic engagement to transform personalised cancer care for improved outcomes cancer care, he added. "With this partnership, we strengthen our commitment to connect ...
Dr Reddy's Laboratories on Thursday said it has joined hands with global biotech firm Alvotech to co-develop and commercialise a biosimilar product for treating multiple types of cancer. The Hyderabad-based drug major has entered into a collaboration and license agreement to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets, Dr Reddy's Laboratories said in a statement. Keytruda (pembrolizumab) is indicated for the treatment of numerous cancer types. In 2024, worldwide sales of Keytruda were USD 29.5 billion. The collaboration combines Dr Reddy's and Alvotech's proven capabilities in biosimilars thereby speeding up the development process and extending the global reach for this biosimilar candidate, the company noted. Under the terms of the agreement, the parties will be jointly responsible for developing and manufacturing the biosimilar candidate and sharing costs and responsibilities, it stated. Subject to certain ...